ProteinQure

ProteinQure leverages quantum molecular simulations and AI to accelerate drug discovery and development, using quantum-enhanced computational methods to model complex molecular interactions and protein dynamics that are challenging for classical computers, enabling more accurate predictions of drug efficacy and safety for pharmaceutical applications.

2025 Developments: The company continues its quantum technology initiatives throughout 2025. Focus remains on advancing core technologies and expanding market presence. Ongoing development activities position the company for future growth in the quantum industry.

Company Information

• Founded: 2017
• Country: Canada
• Website: https://proteinqure.com
• Categories: quantum pharma

Key People

Moe Nadeem (Co-founder, CEO), Trent McConaghy (Co-founder)

Related Companies

Explore other quantum computing companies in similar categories or regions.

← Back to All Companies